Recent developments in microfluidic passive separation to enable purification of platelets for transfusion.

Area of Science:

• Biomedical Engineering
• Hematology
• Cell Separation Technologies

Background:

• Platelet transfusions are critical for treating bleeding but carry risks due to pro-inflammatory contaminants in the supernatant.
• Current methods like leukoreduction filters and centrifugation have limitations in mitigating these risks holistically.
• Existing purification methods are often logistically complex, time-consuming, and labor-intensive.

Purpose of the Study:

• To review recent innovations in microfluidic cell separation for platelet leukoreduction and volume reduction.
• To define performance requirements for effective platelet separation technologies.
• To outline challenges for developing user-friendly, disposable microfluidic devices for platelet purification.

Main Methods:

• Examination of emerging microfluidic technologies for passive cell separation.
• Analysis of performance metrics including leukocyte depletion efficiency, volume reduction, throughput, and platelet recovery.
• Review of conventional methods (leukoreduction filters, centrifugation) and their limitations.

Main Results:

• Microfluidic technologies show promise for cell separation with minimal platelet damage and reduced instrumentation.
• Passive microfluidic separation offers potential for simultaneous leukoreduction and volume reduction.
• Key performance metrics are essential for evaluating new platelet separation methods.

Conclusions:

• Microfluidic devices present a promising alternative to conventional methods for safer platelet transfusions.
• Further development is needed to overcome challenges in creating simple, disposable microfluidic systems for routine clinical use.
• Successful implementation requires devices that effectively reduce volume, remove contaminants, and preserve platelet function.